Pharmaceutical Project Solutions, Inc.

Quick facts

Phase 3 pipeline

• RX0041 4% · Psychiatry
  This drug is a small molecule that targets the serotonin receptor.
• RX0041 8% · Diabetes
  This drug is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• RX0041
• RX0041-002
• RX0041-2

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Pharmaceutical Project Solutions, Inc. portfolio CI brief
• Pharmaceutical Project Solutions, Inc. pipeline updates RSS